002648:SZSESatellite Chemical Co. Ltd. Class A Analysis
Data as of 2026-09-14 - not real-time
CN¥27.22
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Satellite Chemical Co.,Ltd. is priced at ¥27.22 and its moving averages line up in bullish order, the shorter sitting above the longer. The last 30 days have gained 7.7%. RSI sits at 52.5, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at ¥25.68 up to resistance at ¥29.33.
Multiples put this in undervalued territory at a P/E of 10.4. Analyst price targets sit 38.1% above the current price. Revenue is growing at 62.0% on a 16.5% profit margin. The 1.84% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 31.1%, a beta of -0.17 and a maximum drawdown of 28.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 8/10.
Multiples put this in undervalued territory at a P/E of 10.4. Analyst price targets sit 38.1% above the current price. Revenue is growing at 62.0% on a 16.5% profit margin. The 1.84% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 31.1%, a beta of -0.17 and a maximum drawdown of 28.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 8/10.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 23.77
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 23.77
- Analyst targets imply +38.1% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst targets imply +38.1% versus the current price
- Profit margin of 16.5% is healthy
- Revenue growth of +62.0%
Key Metrics & Analysis
Financial Health
Revenue Growth62.00%
Profit Margin16.49%
P/E Ratio10.4
ROE25.41%
ROA9.66%
Debt/Equity69.77
P/B Ratio2.4
Op. Cash FlowCN¥14.2B
Free Cash FlowCN¥9.2B
Technical Analysis
TrendBullish
RSI52.5
SupportCN¥25.68
ResistanceCN¥29.33
MA 20CN¥27.41
MA 50CN¥25.68
MA 200CN¥23.77
MACDBearish
VolumeDecreasing
Fear & Greed Index93.14
Valuation
Fair ValueCN¥87.68
Target PriceCN¥37.58
Upside/Downside38.06%
GradeUndervalued
TypeBlend
Dividend Yield1.84%
Risk Assessment
Beta-0.17
Volatility31.12%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.